Vivek K Gupta Selected Research

Vivek K Gupta Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 10/2013
7	Glaucoma 12/2021 - 04/2014
3	Ganglion Cysts (Ganglion) 09/2020 - 01/2013
3	Tuberculosis (Tuberculoses) 05/2017 - 12/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 10/2017
2	Ocular Hypertension (Glaucoma, Suspect) 01/2021 - 10/2013
1	Hemorrhage 04/2022
1	Ischemia 04/2022
1	Cardiogenic Shock 04/2022
1	Infections 01/2022
1	Multiple Sclerosis 12/2021
1	Stroke (Strokes) 12/2021
1	Parkinson Disease (Parkinson's Disease) 12/2021
1	COVID-19 01/2021
1	Gliosis 10/2020
1	Disease Progression 10/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2020
1	Neoplasms (Cancer) 05/2020
1	Foreign Bodies (Foreign Body) 01/2020
1	Granuloma 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019
1	Circulating Neoplastic Cells 02/2018
1	Inflammation (Inflammations) 10/2017
1	Demyelinating Diseases (Demyelinating Disease) 07/2015
1	type 2 Amaurosis congenita of Leber 11/2013
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2013
1	Breast Neoplasms (Breast Cancer) 12/2009
1	Airway Obstruction (Choking) 01/2004
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2004

Drug/Important Bio-Agent (IBA)

10	Retinaldehyde (Retinal)IBA 01/2021 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2017
3	Amyloid (Amyloid Fibrils)IBA 09/2019 - 01/2016
2	AntioxidantsIBA 05/2020 - 05/2017
2	ProteomeIBA 10/2017 - 01/2017
1	Meropenem (Merrem)FDA LinkGeneric 01/2022
1	Disulfiram (Antabuse)FDA Link 01/2022
1	Inosine Monophosphate (IMP)IBA 01/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 12/2021
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2021
1	CaveolinsIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Amyloid beta-PeptidesIBA 11/2020
1	Glatiramer Acetate (Copaxone)FDA Link 10/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2020
1	Caveolin 1IBA 09/2020
1	Caspase 3 (Caspase-3)IBA 09/2020
1	Glutathione (Reduced Glutathione)IBA 07/2020
1	Carrier Proteins (Binding Protein)IBA 07/2020
1	Crystallins (Crystallin)IBA 07/2020
1	CholesterolIBA 07/2020
1	SiliconesIBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Polysaccharides (Glycans)IBA 02/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2014
1	Hematoxylin (Haematoxylon)IBA 04/2014
1	SilverIBA 04/2014
1	Neuroprotective AgentsIBA 04/2014
1	HexokinaseIBA 11/2013
1	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 10/2013
1	6,7-dihydroxyflavoneIBA 01/2013
1	Volatile Oils (Essential Oils)IBA 12/2012
1	HexanesIBA 12/2012
1	Biological ProductsIBA 12/2009
1	Capsules (Microcapsules)IBA 12/2009
1	PolyelectrolytesIBA 12/2009

Therapy/Procedure

3	Microspheres (Microsphere) 01/2021 - 10/2013
2	Injections 01/2021 - 07/2020
2	Therapeutics 10/2020 - 07/2015
1	Extracorporeal Membrane Oxygenation 04/2022
1	Length of Stay 04/2022
1	Blood Transfusion (Blood Transfusions) 04/2022
1	Immunomodulation 10/2020
1	Immunotherapy 10/2020
1	Intracameral Injection 10/2013
1	Operative Surgical Procedures 01/2004
1	Airway Management 01/2004